Qube Research & Technologies (QRT)’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-125,506
| Closed | -$4.64M | – | 2878 |
|
|
2024
Q2 | $4.64M | Sell |
125,506
-80,658
| -39% | -$2.99M | 0.01% | 1063 |
|
|
2024
Q1 | $8.65M | Buy |
206,164
+161,196
| +358% | +$6.77M | 0.01% | 790 |
|
|
2023
Q4 | $1.78M | Buy |
44,968
+40,669
| +946% | +$1.61M | ﹤0.01% | 1341 |
|
|
2023
Q3 | $118K | Sell |
4,299
-64,548
| -94% | -$1.78M | ﹤0.01% | 2186 |
|
|
2023
Q2 | $2.34M | Buy |
68,847
+6,902
| +11% | +$234K | 0.01% | 917 |
|
|
2023
Q1 | $2.23M | Buy |
61,945
+28,271
| +84% | +$1.02M | 0.01% | 896 |
|
|
2022
Q4 | $1.5M | Buy |
33,674
+26,198
| +350% | +$1.17M | 0.01% | 981 |
|
|
2022
Q3 | $210K | Buy |
+7,476
| New | +$210K | ﹤0.01% | 1713 |
|
|
2021
Q2 | – | Sell |
-64,913
| Closed | -$1.34M | – | 2313 |
|
|
2021
Q1 | $1.34M | Sell |
64,913
-106,405
| -62% | -$2.19M | 0.02% | 732 |
|
|
2020
Q4 | $3M | Buy |
171,318
+97,734
| +133% | +$1.71M | 0.04% | 461 |
|
|
2020
Q3 | $1.09M | Buy |
73,584
+37,250
| +103% | +$552K | 0.02% | 787 |
|
|
2020
Q2 | $472K | Buy |
+36,334
| New | +$472K | 0.01% | 1138 |
|